NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Cofounder Huda Ammori calls into question the pro-Palestine group’s ban under ‘antiterrorism’ laws.Read More